<p>Bars represent the IC50 ± SD (average values from at least three independent experiments) for oxaliplatin for each condition. Insets show PKM2 and p53 inmunoblotting after PKM2 gene silencing. Specific IC50 values for oxaliplatin in all conditions are displayed in the table. IC50 values for Mock conditions (without transfection) were very similar to those of siNTC and are not shown. *p-values are result of comparison to the siNTC condition. * <i>P- value</i> < 0.05. ** <i>P-value <</i> 0.01; *** <i>P-value <</i> 0.001</p
<p>The results are given in fold-change. The concentrations used were MX 0.6 µM, 1 µM and 1 µM in He...
<p>A) Immunofluorescence (IF) staining of MMP7 in the non-resistant (HT29, HCT116 p53<sup>+/+</sup>,...
<p>HeLa Control and HeLa Bid kd cells were treated with the indicated concentrations of Oxaliplatin ...
Ajuts: Beca bianual de la Fundació Olga Torres 2008-2009Chemoresistance is the main cause of treatme...
<div><p>Chemoresistance is the main cause of treatment failure in advanced colorectal cancer (CRC). ...
Chemoresistance is the main cause of treatment failure in advanced colorectal cancer (CRC). However,...
Chemoresistance is the main cause of treatment failure in advanced colorectal cancer (CRC). However,...
<p>Changes in BMF gene expression between OXA treated (T) and non-treated (NT) HT29, siPKM2- HT29 an...
<p>(<b>A</b>) Immunoblot analysis of p53 levels in H1299 p53γ and H1299 p53β cells after treatment w...
<p>After siRNA transfection cells were treated with 15 μM OXA for 24 h period, observed by optical m...
Ajuts: Beca bianual de la Fundació Olga Torres 2008-2009Chemoresistance is the main cause of treatme...
<p>(<b>A</b>) Immunoblot analyses of transfected wild-type HA-p53 expression (anti-HA antibody), tot...
<p>(A, B) CX-1 and HCT116 cells were exposed to normothermic or hyperthermic (42°C) conditions for 1...
(a) Immunohistochemical staining with anti-PKM2 antibodies was performed on 167 OSCC TMA. The microg...
<p>A) The effect of oxaliplatin on the viability of human colorectal cancer cells. Caco-2, SW1116 an...
<p>The results are given in fold-change. The concentrations used were MX 0.6 µM, 1 µM and 1 µM in He...
<p>A) Immunofluorescence (IF) staining of MMP7 in the non-resistant (HT29, HCT116 p53<sup>+/+</sup>,...
<p>HeLa Control and HeLa Bid kd cells were treated with the indicated concentrations of Oxaliplatin ...
Ajuts: Beca bianual de la Fundació Olga Torres 2008-2009Chemoresistance is the main cause of treatme...
<div><p>Chemoresistance is the main cause of treatment failure in advanced colorectal cancer (CRC). ...
Chemoresistance is the main cause of treatment failure in advanced colorectal cancer (CRC). However,...
Chemoresistance is the main cause of treatment failure in advanced colorectal cancer (CRC). However,...
<p>Changes in BMF gene expression between OXA treated (T) and non-treated (NT) HT29, siPKM2- HT29 an...
<p>(<b>A</b>) Immunoblot analysis of p53 levels in H1299 p53γ and H1299 p53β cells after treatment w...
<p>After siRNA transfection cells were treated with 15 μM OXA for 24 h period, observed by optical m...
Ajuts: Beca bianual de la Fundació Olga Torres 2008-2009Chemoresistance is the main cause of treatme...
<p>(<b>A</b>) Immunoblot analyses of transfected wild-type HA-p53 expression (anti-HA antibody), tot...
<p>(A, B) CX-1 and HCT116 cells were exposed to normothermic or hyperthermic (42°C) conditions for 1...
(a) Immunohistochemical staining with anti-PKM2 antibodies was performed on 167 OSCC TMA. The microg...
<p>A) The effect of oxaliplatin on the viability of human colorectal cancer cells. Caco-2, SW1116 an...
<p>The results are given in fold-change. The concentrations used were MX 0.6 µM, 1 µM and 1 µM in He...
<p>A) Immunofluorescence (IF) staining of MMP7 in the non-resistant (HT29, HCT116 p53<sup>+/+</sup>,...
<p>HeLa Control and HeLa Bid kd cells were treated with the indicated concentrations of Oxaliplatin ...